The company returned the stolen money to the state and the region
The pharmaceutical company Bracco could soon return to providing scientific information. According to the prosecutor Ciro Angelillis, owner of the max investigation into the farmafraffa in Bari, the disqualification measure he requested a few months ago for Bracco and eight other companies involved in the scandal can be revoked: Glaxo, Biofutura, Bristol, Novartis, AstraZeneca, Lusofarmaco, Recordati and Pfizer. Bracco compensated the damage caused to the Puglia Region and the State with incorrect organizational management of the structure, which had allowed some scientific representatives to agree with doctors and pharmacists to sponsor their drugs. But in recent times the pharmaceutical company has run for cover, modifying its organizational models and then compensating for the damage. For the prosecutor everything is now in order and therefore the company can go back to work. Hence the request for revocation of the disqualification, on which the investigating judge Chiara Civitano will now pronounce. The Republic of 11/17/2007 ed. Bari p. 6
